Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026

GlobeNewswire

08/04

GARDEN CITY, N.Y., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.

Conference Call & Webcast
*Thursday, August 13th @ 8 a.m. ET*
Domestic:	1-877-407-0784
International:	1-201-689-8560
Conference ID:	13762077

Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.

About Beyond Air, Inc.
Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.

CONTACTS:

Corey Davis, Ph.D.
LifeSci Advisors, LLC
Cdavis@lifesciadvisors.com
(212) 915-2577

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2656556465"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2656556465\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2656556465?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-04 20:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2656556465","market":"sh","top_or_hot":-1,"title":"Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026","media":"GlobeNewswire","content":"<html><body><p>GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a>, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.</p> <table><tr><td><strong>Conference Call &amp; Webcast</strong></td><td> </td></tr><tr><td><strong><em><u>Thursday, August 13th @ 8 a.m. ET</u></em></strong></td><td> </td></tr><tr><td><strong>Domestic:</strong>  </td><td>1-877-407-0784</td></tr><tr><td><strong>International:</strong> </td><td>1-201-689-8560</td></tr><tr><td><strong>Conference ID:</strong></td><td>13762077</td></tr></table> <p><strong>Webcast: </strong>A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.</p> <p><strong>About Beyond Air, Inc.</strong><br/>Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.</p> <p><strong>CONTACTS:</strong></p> <p>Corey Davis, Ph.D.<br/>LifeSci Advisors, LLC<br/><u>Cdavis@lifesciadvisors.com</u> <br/>(212) 915-2577</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/YzJmNGI1MzItZjQ0Zi00Mjk3LWIzZTktY2E0Nzk2MzczYzhjLTEwOTU0OTktMjAyNi0wOC0wNC1lbg==/tiny/Beyond-Air-.png\"/></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Beyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBeyond Air Schedules Conference Call to Discuss Financial Results for the Quarter Ended June 30, 2026\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1016364462\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">GlobeNewswire </p>\n<p class=\"h-time smaller\">2026-08-04 20:00</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p>GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- <a href=\"https://laohu8.com/S/XAIR\">Beyond Air</a>, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day.</p> <table><tr><td><strong>Conference Call &amp; Webcast</strong></td><td> </td></tr><tr><td><strong><em><u>Thursday, August 13th @ 8 a.m. ET</u></em></strong></td><td> </td></tr><tr><td><strong>Domestic:</strong>  </td><td>1-877-407-0784</td></tr><tr><td><strong>International:</strong> </td><td>1-201-689-8560</td></tr><tr><td><strong>Conference ID:</strong></td><td>13762077</td></tr></table> <p><strong>Webcast: </strong>A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call.</p> <p><strong>About Beyond Air, Inc.</strong><br/>Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net.</p> <p><strong>CONTACTS:</strong></p> <p>Corey Davis, Ph.D.<br/>LifeSci Advisors, LLC<br/><u>Cdavis@lifesciadvisors.com</u> <br/>(212) 915-2577</p> <br/><img referrerpolicy=\"no-referrer-when-downgrade\" src=\"https://ml.globenewswire.com/media/YzJmNGI1MzItZjQ0Zi00Mjk3LWIzZTktY2E0Nzk2MzczYzhjLTEwOTU0OTktMjAyNi0wOC0wNC1lbg==/tiny/Beyond-Air-.png\"/></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4581","symbol_name":"高盛持倉","start_time":0,"source_url":"https://www.globenewswire.com/news-release/2026/08/04/3338217/0/en/Beyond-Air-Schedules-Conference-Call-to-Discuss-Financial-Results-for-the-Quarter-Ended-June-30-2026.html","article_id":"2656556465","we_media_id":"1016364462","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2656556465","pubTimestamp":1785844800,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"GlobeNewswire","introduction":"Share your news with media, investors, and consumers with targeted distribution options from one of the world’s largest and most trusted newswires.","home_visible":1,"id":"1016364462","head_image":"https://static.tigerbbs.com/31bb960c88eab45f27ccc9fce75dee9a"},"summary":"GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (「Beyond Air」 or the 「Company」), a commercial-stage medical device and biopharmaceutical company focused on harne","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4581":"高盛持仓","MDST":"Westwood Salient Enhanced Midstream Income ETF","TPZ":"Tortoise Electrification Infrastructure ETF","BK4144":"石油与天然气的储存和运输","BK4590":"PTP","XAIR":"BEYOND AIR INC","BK4585":"ETF&股票定投概念","MLPA":"Global X MLP ETF","ET":"Energy Transfer LP","ENFR":"Alerian Energy Infrastructure ET","UMI":"USCF Midstream Energy Income Fund","EMLP":"第一信托北美能源基础设施基金","BK4082":"医疗保健设备","TNGY":"Tortoise Energy Fund","EIPI":"FT Energy Income Partners Enhanced Income Etf","EIPX":"FT ENERGY INCOME PARTNERS STRATEGY ETF","BK4588":"碎股","AMLP":"Alerian MLP ETF","AMZA":"InfraCap MLP ETF","USAI":"Pacer American Energy Independence ETF","BK4561":"索罗斯持仓"},"translate_title":"Beyond Air 安排电话会议讨论截至 2026 年 6 月 30 日的季度财务业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ET":1,"AMLP":0.6,"EMLP":0.6,"XAIR":1,"MDST":0.6,"MLPA":0.6,"EIPI":0.6,"TPZ":0.6,"AMZA":0.6,"ENFR":0.6,"EIPX":0.6,"USAI":0.6,"TNGY":0.6,"UMI":0.6},"content_text":"GARDEN CITY, N.Y., Aug.  04, 2026  (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (「Beyond Air」 or the 「Company」), a commercial-stage medical device and biopharmaceutical company focused on harnessing the power of nitric oxide (NO) to improve patients' lives, today announced that it will report financial results for its quarter ended June 30, 2026 on Thursday, August 13, 2026. The Company's management team is scheduled to host a conference call and webcast at 8:00 a.m. Eastern Time (ET) the same day. Conference Call & Webcast Thursday, August 13th @ 8 a.m. ET Domestic:  1-877-407-0784International: 1-201-689-8560Conference ID:13762077 Webcast: A webcast of the live conference call can be accessed by visiting the Events section of the Company’s website (click here) or directly (click here). An online replay will be available on the Company’s website or via the direct link an hour after the call. About Beyond Air, Inc.Beyond Air is a commercial-stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. The Company has received FDA approval and CE Mark for its first system, LungFit PH, for the treatment of term and near-term neonates with hypoxic respiratory failure. For more information, visit www.beyondair.net. CONTACTS: Corey Davis, Ph.D.LifeSci Advisors, LLCCdavis@lifesciadvisors.com (212) 915-2577","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}